ChemicalBook > CAS DataBase List > Sotrovimab

Sotrovimab

Product Name
Sotrovimab
CAS No.
2423014-07-5
Chemical Name
Sotrovimab
Synonyms
Sotrovimab;Research Grade Sotrovimab;Sotrovimab (anti-Spike RBD);Research Grade Sotrovimab(DVV00307)
CBNumber
CB512204956
Formula Weight
0
MOL File
Mol file
More
Less

Sotrovimab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Sotrovimab Chemical Properties,Usage,Production

Uses

Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease[1][2].

in vivo

Sotrovimab (5 mg/kg, 10 mL; via intravenous catheter; single dose) provides protective exposures against susceptible variants in the lung of female cynomolgus monkey for up to 28?days[3].

References

[1] Gupta A, et al; COMET-ICE Investigators. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. N Engl J Med. 2021 Nov 18;385(21):1941-1950. DOI:10.1056/NEJMoa2107934
[2] Case JB, et al. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains. Nat Commun. 2022 Jul 2;13(1):3824. DOI:10.1038/s41467-022-31615-7
[3] Cathcart A L, et al. The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2[J]. biorxiv, 2022: 2021.03. 09.434607.
[4] Aweda TA, et al. In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys. Eur J Nucl Med Mol Imaging. 2022 Oct 28:1–12. DOI:10.1007/s00259-022-06012-3

Sotrovimab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Sotrovimab Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58

2423014-07-5, SotrovimabRelated Search:


  • Sotrovimab
  • Research Grade Sotrovimab(DVV00307)
  • Research Grade Sotrovimab
  • Sotrovimab (anti-Spike RBD)
  • 2423014-07-5